Abstract:The ongoing COVID-19 pandemic has caused dramatic loss of human life. There is an urgent need for safe and efficient anti-coronavirus infection drugs. Anti-coronavirus peptides (ACovPs) can inhibit coronavirus infection. With high-efficiency, low-toxicity, and broad-spectrum inhibitory effects on coronaviruses, they are promising candidates to be developed into a new type of anti-coronavirus drug. Experiment is the traditional way of ACovPs' identification, which is less efficient and more expensive. With the accumulation of experimental data on ACovPs, computational prediction provides a cheaper and faster way to find anti-coronavirus peptides' candidates. In this study, we ensemble several state-of-the-art machine learning methodologies to build nine classification models for the prediction of ACovPs. These models were pre-trained using deep neural networks, and the performance of our ensemble model, ACP-Dnnel, was evaluated across three datasets and independent dataset. We followed Chou's 5-step rules. (1) we constructed the benchmark datasets data1, data2, and data3 for training and testing, and introduced the independent validation dataset ACVP-M; (2) we analyzed the peptides sequence composition feature of the benchmark dataset; (3) we constructed the ACP-Dnnel model with deep convolutional neural network (DCNN) merged the bi-directional long short-term memory (BiLSTM) as the base model for pre-training to extract the features embedded in the benchmark dataset, and then, nine classification algorithms were introduced to ensemble together for classification prediction and voting together; (4) tenfold cross-validation was introduced during the training process, and the final model performance was evaluated; (5) finally, we constructed a user-friendly web server accessible to the public at http://150.158.148.228:5000/ . The highest accuracy (ACC) of ACP-Dnnel reaches 97%, and the Matthew's correlation coefficient (MCC) value exceeds 0.9. On three different datasets, its average accuracy is 96.0%. After the latest independent dataset validation, ACP-Dnnel improved at MCC, SP, and ACC values 6.2%, 7.5% and 6.3% greater, respectively. It is suggested that ACP-Dnnel can be helpful for the laboratory identification of ACovPs, speeding up the anti-coronavirus peptide drug discovery and development. We constructed the web server of anti-coronavirus peptides' prediction and it is available at http://150.158.148.228:5000/ .

ACVPICPred: inhibitory activity prediction of anti-coronavirus peptides based on artificial neural network

ACVPred: Enhanced prediction of anti-coronavirus peptides by transfer learning combined with data augmentation

ACP-Dnnel: anti-coronavirus peptides' prediction based on deep neural network ensemble learning

Current Development of Data Resources and Bioinformatics Tools for Anticoronavirus Peptide

FEOpti-ACVP: identification of novel anti-coronavirus peptide sequences based on feature engineering and optimization

EACVP: An ESM-2 LM Framework Combined CNN and CBAM Attention to Predict Anti-coronavirus Peptides

iACVP-MR: Accurate Identification of Anti-coronavirus Peptide based on Multiple Features Information and Recurrent Neural Network

AntiCVP-Deep: Identify Anti-Coronavirus Peptides Between Different Negative Datasets Based on Self-Attention and Deep Learning

A two-stage computational framework for identifying antiviral peptides and their functional types based on contrastive learning and multi-feature fusion strategy

AI4AVP: an antiviral peptides predictor in deep learning approach with generative adversarial network data augmentation

iDVEIP: A computer‐aided approach for the prediction of viral entry inhibitory peptides

Synthetic Peptides Outside the Spike Protein Heptad Repeat Regions As Potent Inhibitors of Sars-Associated Coronavirus

ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides

ACEiPP: A Deep Learning-Based Framework to Predict Angiotensin-Converting Enzyme (ACE)-Inhibitory Peptides Using High-Efficiency Amino Acid Descriptors

Innovative Alignment-Based Method for Antiviral Peptide Prediction

Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides

Predicting drug-Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2

DeepAVP-TPPred: identification of antiviral peptides using transformed image-based localized descriptors and binary tree growth algorithm

Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding

Pred-AHCP: Robust feature selection enabled Sequence-Specific Prediction of Anti-Hepatitis C Peptides via Machine Learning

Improved prediction of anti-angiogenic peptides based on machine learning models and comprehensive features from peptide sequences